Dashboard
Manage Tickers

IART


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

truist-securities-reiterates-hold-on-integra-lifesciences-lowers-price-target-to-13
Truist Securities Reiterates Hold on Integ...
11/03/2025 15:25:27

Truist Securities analyst Ravi Misra reiterates Integra Lifesciences (NASDAQ:IART) with a Hold and lowers the price target f...

citigroup-maintains-sell-on-integra-lifesciences-lowers-price-target-to-11
Citigroup Maintains Sell on Integra Lifesc...
10/31/2025 20:18:35

Citigroup analyst Joanne Wuensch maintains Integra Lifesciences (NASDAQ:IART) with a Sell and lowers the price target from $...

jp-morgan-maintains-underweight-on-integra-lifesciences-raises-price-target-to-13
JP Morgan Maintains Underweight on Integra...
10/31/2025 18:40:16

JP Morgan analyst Robbie Marcus maintains Integra Lifesciences (NASDAQ:IART) with a Underweight and raises the price target ...

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
10/30/2025 17:07:10

earnings-scheduled-for-october-30-2025
Earnings Scheduled For October 30, 2025
10/30/2025 11:12:06

integra-lifesciences-sees-q4-adj-eps-079-084-vs-092-est-sees-sales-420000m-440000m-vs-456197m-est
Integra Lifesciences Sees Q4 Adj EPS $0.79...
10/30/2025 10:02:06

Integra Lifesciences (NASDAQ:IART) is looking for Q4 Adj EPS of $0.79-$0.84 vs $0.92 analyst estimate. sees sales of $420.000 m...

integra-lifesciences-narrows-fy2025-adj-eps-guidance-from-219-229-to-219-224-vs-221-est-lowers-fy2025-sales-guidance-from-1655b-1680b-to-1620b-1640b-vs-1669b-est
Integra Lifesciences Narrows FY2025 Adj EP...
10/30/2025 10:01:49

Integra Lifesciences (NASDAQ:IART) narrows FY2025 Adj EPS guidance from $2.19-$2.29 to $2.19-$2.24 vs $2.21 analyst estimate. L...

integra-lifesciences-q3-adj-eps-054-beats-043-estimate-sales-402062m-miss-414256m-estimate
Integra Lifesciences Q3 Adj. EPS $0.54 Bea...
10/30/2025 10:00:56

Integra Lifesciences (NASDAQ:IART) reported quarterly earnings of $0.54 per share which beat the analyst consensus estimate of ...

truist-securities-maintains-hold-on-integra-lifesciences-raises-price-target-to-15
Truist Securities Maintains Hold on Integr...
10/15/2025 15:14:24

Truist Securities analyst Richard Newitter maintains Integra Lifesciences (NASDAQ:IART) with a Hold and raises the price tar...

integra-lifesciences-to-showcase-new-neurosurgical-innovations-at-cns-2025-in-los-angeles-october-11-through-15-2025
Integra LifeSciences To Showcase New Neuro...
10/08/2025 12:42:47

- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, is pleased to announce ...

integra-lifesciences-affirms-fy2025-adj-eps-guidance-of-219-229-vs-224-est-narrows-fy2025-sales-guidance-from-1650b-1715b-to-1655b-1680b-vs-1667b-est
Integra Lifesciences Affirms FY2025 Adj EP...
07/31/2025 10:08:25

Integra Lifesciences (NASDAQ:IART) affirms FY2025 Adj EPS guidance from $2.19-$2.29 to $2.19-$2.29 vs $2.24 analyst estimate. N...

integra-lifesciences-sees-q3-adj-eps-040-045-vs-058-est-sees-sales-410000m-420000m-vs-418831m-est
Integra Lifesciences Sees Q3 Adj EPS $0.40...
07/31/2025 10:07:32

Integra Lifesciences (NASDAQ:IART) is looking for Q3 Adj EPS of $0.40-$0.45 vs $0.58 analyst estimate. sees sales of $410.000 m...

integra-lifesciences-q2-adj-eps-045-beats-043-estimate-sales-415605m-beat-395067m-estimate
Integra Lifesciences Q2 Adj. EPS $0.45 Bea...
07/31/2025 10:04:50

Integra Lifesciences (NASDAQ:IART) reported quarterly earnings of $0.45 per share which beat the analyst consensus estimate of ...

Core News & Articles
Earnings Scheduled For July 31, 2025
07/31/2025 08:32:50

fda-announces-applicator-recall-integra-lifesciences-removes-micromyst-applicators-due-to-potential-sterility-concerns
FDA Announces Applicator Recall: Integra L...
07/21/2025 15:26:11

https://www.fda.gov/medical-devices/medical-device-recalls/applicator-recall-integra-lifesciences-removes-micromyst-applicators...

cranial-drill-recall-integra-lifesciences-recalls-codman-disposable-perforators-due-to-risk-of-device-disassembly---fda
'Cranial Drill Recall: Integra LifeScience...
07/16/2025 19:10:22

https://www.fda.gov/medical-devices/medical-device-recalls/cranial-drill-recall-integra-lifesciences-recalls-codman-disposable-...

integra-lifesciences-announces-first-patient-has-enrolled-in-acclarent-aera-pediatric-registry
Integra LifeSciences Announces First Patie...
07/02/2025 20:09:42

jmp-securities-maintains-market-outperform-on-integra-lifesciences-lowers-price-target-to-25
JMP Securities Maintains Market Outperform...
05/09/2025 15:01:16

JMP Securities analyst David Turkaly maintains Integra Lifesciences (NASDAQ:IART) with a Market Outperform and lowers the pr...

jp-morgan-maintains-underweight-on-integra-lifesciences-lowers-price-target-to-12
JP Morgan Maintains Underweight on Integra...
05/06/2025 14:15:54

JP Morgan analyst Robbie Marcus maintains Integra Lifesciences (NASDAQ:IART) with a Underweight and lowers the price target ...

wells-fargo-maintains-equal-weight-on-integra-lifesciences-lowers-price-target-to-13
Wells Fargo Maintains Equal-Weight on Inte...
05/06/2025 13:29:51

Wells Fargo analyst Vik Chopra maintains Integra Lifesciences (NASDAQ:IART) with a Equal-Weight and lowers the price target ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION